Neptune Responds to Aker BioMarine's Attempt to Shift the Focus From Neptune's Major ITC Filing

LAVAL, Quebec, Jan. 31, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) the pioneer in the krill oil industry, recently announced the filing of a complaint in the United States International Trade Commission (the "ITC") against multiple infringers, including Aker BioMarine ("Aker"), for infringement of U.S. Patent No. 8,278,351, which contains composition of matter claims. Aker, in a clear attempt to shift the focus from the ITC action, has issued a press release addressing the re-examination of a different Neptune patent that is directed to methods of use.

"Neptune has known of the action in the re-examination of the methods of use patent for days and recognizes it for what it is: a simple procedural step in the long process of re-examination," said Benoit Huart, Director of Legal Affairs of Neptune. "Aker relies on the industry's inexperience with patent litigation and is trying to sidestep the fact that Neptune has made a significant litigation filing that allows for a fast resolution of infringement and the potential for broad and severe remedies," he added. "The recent press release Aker issued is consistent with its strategy of denigrating our patents to deflect attention from its infringement," he concluded.